tirzepatide is it fda approved approval tirzepatide safe for weight loss? Tirzepatide is an FDA-approved medication used Lilly's new drug Mounjaro (tirzepatide

Description

This fear can become paralyzing if left unchecked

Key points: GI side effects are most common: nausea, diarrhea, and decreased appetite They usually improve: most patients adapt within 4-8 weeks Start low, go slow: the escalation schedule exists for a reason Stay hydrated and modify your diet: simple changes make a big difference Communicate with your provider: don't suffer unnecessarily Sources SURMOUNT-1 Clinical Trial (Jastreboff et al., NEJM 2022) SURPASS-1 Clinical Trial (Rosenstock et al., NEJM 2021) Mounjaro Prescribing Information, Eli Lilly Zepbound Prescribing Information, Eli Lilly Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice

Shima Hadidchi MD Family Practice We understand that every patients journey is unique

Nausea can be mild or severe, depending on the individuals reaction to the drug

Some clinicians and researchers explore split semaglutide dosing twice weekly or split tirzepatide dosing as a way to maintain more consistent blood levels and potentially improve results while reducing peak-dose side effects